帕金森病的生物学定义:分子影像的关键作用
本文综述帕金森病(PD)从临床综合征向生物学定义疾病的概念转变,综合神经病理学、遗传学和生物标志物研究进展,重点阐述分子影像在新兴生物学框架中的核心作用。文章讨论多巴胺能显像、[18F]FDG PET和心脏[123I]MIBG闪烁显像等影像生物标志物提供神经退行性变的客观体内测量,并综述α-突触核蛋白PET示踪剂开发现状。
要点
- 多巴胺能显像、[18F]FDG PET和心脏[123I]MIBG显像可提供神经退行性变的客观体内测量。
- 分子影像可补充α-突触核蛋白种子扩增检测和遗传分层。
- 生物标志物驱动的分类系统对患者分层和疾病修饰治疗试验设计日益重要。
核心结论
- 分子影像将成为帕金森病未来精准医学方法的基石。
研究设计与样本
- 综述性文章,综合神经病理学、遗传学和生物标志物研究进展,未报告系统检索范围。
主要发现
- 已建立的影像生物标志物包括多巴胺能显像、[18F]FDG PET和心脏[123I]MIBG闪烁显像,可提供神经退行性变的客观体内测量。
- α-突触核蛋白PET示踪剂尚处于开发阶段,其直接可视化疾病定义性病理的潜力有待评估。
临床怎么用
- 分子影像生物标志物可用于帕金森病患者分层及疾病修饰治疗试验设计。
局限性
- 实施基于生物学的疾病定义面临科学、方法学和伦理方面的关键挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this article, we outline the ongoing conceptual transition of Parkinson disease (PD) from a clinically defined syndrome to a biologically defined disorder. We synthesize recent advances in neuropathology, genetics, and biomarker research, with particular emphasis on the central role of molecular imaging within emerging biology-based frameworks. We discuss how established imaging biomarkers-including dopaminergic imaging, [18F]FDG PET, and cardiac [123I]MIBG scintigraphy-provide objective in vivo measures of neurodegeneration that complement α-synuclein seed amplification assays and genetic stratification. In addition, we review the current state of α-synuclein PET tracer development and critically evaluate its potential to enable direct visualization of disease-defining pathology in vivo. We highlight the growing importance of biomarker-driven classification systems for patient stratification and the design of trials of disease-modifying therapies in PD. At the same time, we address key scientific, methodologic, and ethical challenges associated with implementing biologically grounded disease definitions. Together, these developments position molecular imaging as a cornerstone of future precision medicine approaches in PD.
引用
- Brendel M, Barthel H, Höglinger GU, et al. Biologic Definition of Parkinson Disease: A Pivotal Role for Molecular Imaging. J Nucl Med. 2026. PMID: 42020151. doi:10.2967/jnumed.125.271573
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。